Veterans Affairs Insurance Disparities for Metastatic Lung Cancer in the Hawaiian Islands
- PMID: 34589910
- PMCID: PMC8474251
- DOI: 10.1016/j.jtocrr.2020.100003
Veterans Affairs Insurance Disparities for Metastatic Lung Cancer in the Hawaiian Islands
Abstract
Introduction: The highest concentration of military personnel in the United States is located in Hawaii where occupational exposures, such as to asbestos in the Pacific Fleet shipyards, predispose them to thoracic malignancies. For this reason, Veterans Affairs (VA) insurance outcomes for lung cancer in Hawaii are of interest.
Methods: All cases of lung cancer in the Hawaii Tumor Registry from 2000 to 2015 were evaluated. The selection criterion included evidence of extensive-stage SCLC (ES-SCLC) or metastatic NSCLC. Overall survival was compared using the Kaplan-Meier log-rank method. Univariate analysis and multivariable analysis (MVA) were carried out to understand the variables associated with overall survival.
Results: There were 434 cases of ES-SCLC and 2139 cases of metastatic NSCLC identified. VA insurance (median survival [MS], 2 mo), Medicaid (MS, 4 mo), and Medicare (MS, 4 mo) had worse survival (log-rank p < 0.001) than private insurance (MS, 8 mo). In ES-SCLC, VA insurance (hazard ratio [HR], 2.74; 95% confidence interval [CI]: 1.50-5.01; p = 0.001) and Medicaid (HR, 1.46; 95% CI: 1.04-2.03; p = 0.027) had significantly worse survival compared with private insurance on MVA. VA insurance (HR, 1.84; 95% CI: 1.34-2.53; p < 0.001) and Medicaid (HR, 1.40; 95% CI: 1.20-1.63; p < 0.001) also had worse survival compared with private insurance in metastatic NSCLC on MVA.
Conclusions: VA insurance coverage was associated with dismal survival for metastatic lung cancer that was effectively similar to hospice or supportive care, compelling further investigation to identify reasons for this disparity.
Keywords: Hawaii; Non–small cell lung cancer; Small cell lung cancer; Veterans Affairs.
© 2020 The Authors.
Figures
Similar articles
-
Association of Medicaid Insurance With Survival Among Patients With Small Cell Lung Cancer.JAMA Netw Open. 2020 Apr 1;3(4):e203277. doi: 10.1001/jamanetworkopen.2020.3277. JAMA Netw Open. 2020. PMID: 32320035 Free PMC article.
-
Insurance Status is an Independent Predictor of Overall Survival in Patients With Stage III Non-small-cell Lung Cancer Treated With Curative Intent.Clin Lung Cancer. 2020 May;21(3):e130-e141. doi: 10.1016/j.cllc.2019.08.009. Epub 2019 Sep 18. Clin Lung Cancer. 2020. PMID: 31708388
-
Access to kidney transplantation among patients insured by the United States Department of Veterans Affairs.J Am Soc Nephrol. 2007 Sep;18(9):2592-9. doi: 10.1681/ASN.2007010050. Epub 2007 Aug 8. J Am Soc Nephrol. 2007. PMID: 17687075
-
An official American Thoracic Society systematic review: insurance status and disparities in lung cancer practices and outcomes.Am J Respir Crit Care Med. 2010 Nov 1;182(9):1195-205. doi: 10.1164/rccm.2009-038ST. Am J Respir Crit Care Med. 2010. PMID: 21041563 Review.
-
Chemotherapy versus best supportive care for extensive small cell lung cancer.Cochrane Database Syst Rev. 2013 Nov 27;(11):CD001990. doi: 10.1002/14651858.CD001990.pub3. Cochrane Database Syst Rev. 2013. PMID: 24282143 Review.
Cited by
-
Survival among lung cancer patients: comparison of the U.S. military health system and the surveillance, epidemiology, and end results (SEER) program by health insurance status.Cancer Causes Control. 2024 Jan;35(1):21-31. doi: 10.1007/s10552-023-01765-0. Epub 2023 Aug 2. Cancer Causes Control. 2024. PMID: 37532916
References
LinkOut - more resources
Full Text Sources